Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
$169 Get a free consultation Dont hesitate to contact us for any questions and consulatation.
2142-A ASSOCIATION BETWEEN SARCOPENIA AND CORONARY ATHEROSCLEROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE Yeonjung Ha, Young Eun Chon, Joo Ho Lee and Kwan Sik Lee, CHA Bundang Medical Center, CHA University Background: The aim of this study was to examine the impact of sarcopenia on coronary atherosclerosis in patients with metabolic dysfunction-associated fatty liver disease (MAFLD)
No heterogeneity was presented in the included studies (I 2 = 0%, P = 0.39), and we used the fixed effects model (Fig
Lower Risk of Cardiovascular Problems: Studies show that semaglutide can help reduce the risk of major cardiovascular events, like heart attacks and strokes, in people with diabetes
US$ 25.40
US$ 20.11
US$ 21.23
